Basic Infection Prevention and Care of the Immunocompromised Patient Flashcards
Myelosuppression
refers to a process that disrupts these stem cells and, consequently, affects all of the different types of blood cells: red blood cells, white blood cells, and platelets. This condition manifests as a decrease in neutrophils, megakaryocytes, and erythrocytes in the bone marrow.
Myelosuppression is the most common dose-limiting toxicity of chemotherapy. Most chemotherapy agents cause some degree of myelosuppression. The severity depends on the agent’s mechanism of action and the overall treatment plan.
Neutropenia
a significant reduction in the absolute number of circulating neutrophils in the blood. An absolute neutrophil count (ANC) of less than 1,500/mm3 defines neutropenia. The severity of a patient’s neutropenia is related to the relative risk for infection.
Mild: ANC less than the lower limit of normal to 1,500/mm3
Moderate: ANC less than 1,500/mm3 to 1,000/mm3
Severe: ANC less than 1,000/mm3 to 500/mm3
Life-threatening: ANC less than 500/mm3
Anemia
is most commonly diagnosed and graded by tracking the patient’s hemoglobin level. A hemoglobin of 11g/dl or lower or 2g/dl or greater below baseline indicates anemia. Although hematocrit or red blood cell count can also be used to determine anemia, hemoglobin is most commonly used because it reflects physiologic consequences.
Thrombocytopenia
is present when a patient’s platelet count is less than 140x10 / L.
Nadir
A patient will most commonly experience a nadir 8-12 days after receiving cytotoxic therapy. Nadir is the term used to describe the time at which the blood counts reach their lowest level. Recovery occurs about 21-28 days after chemotherapy administration.
cell cycle specific agents
Generally, cell cycle-specific agents are less damaging because they primarily affect the cell in a specific phase of the cell cycle.
Severe neutropenia can occur when cell cycle-specific agents are used in dose-intensification and combination regimens.
Example medications include antimetabolites.
cell cycle nonspecific agents
Cell cycle-nonspecific agents cause more damage to stem cells because they affect the cell in all phases of the cell cycle.
The extent of neutropenia is dependent on the dose, schedule, and agent.
Some cell cycle-nonspecific agents (e.g., nitrosoureas) can cause delayed and prolonged neutropenia.
Nadir can occur at three to five weeks, with recovery ranging from one to two weeks to as many as to five to six weeks.
Example medications include alkylating agents and nitrosoureas.
What puts a patient at higher risk for infection?
Advanced age; age of older than 65 years for chemotherapy-induced neutropenia (CIN)
Low neutrophil count at the start of treatment
Tumor involvement in bone marrow
Poor performance status
Renal dysfunction
Liver dysfunction
Previous myelosuppressive chemotherapy or radiation therapy
A history of severe neutropenia with similar chemotherapy
Preexisting infection, including open wounds or recent surgery
Hematologic malignancy and uncontrolled or advanced cancer (e.g., lung cancer has an increased risk of CIN)
Chemotherapy regimen (e.g., relative dose intensity of greater than 80%, dose-dense chemotherapy)
Use of specific medications, phenothiazines, diuretics, and immunosuppressive drug
Signs and Symptoms of Infection
Neutropenic patients may lack the needed neutrophils to illicit an immune response and manifest classic signs of infection, such as redness, edema, and purulent discharge.
Fever greater than 100.4°F (38°C) is the most reliable sign or symptom of infection in patients with neutropenia. In many instances, neutropenic fevers are considered an emergency requiring immediate action.
Febrile neutropenia
Defined as a one-time oral temperature greater than 101°F (38.3°C) or a temperature of 100.4°F (38°C) lasting for an hour. Febrile neutropenia occurs when ANC is less than 500/mm3 or less than 1,000 mm3 with an anticipated drop to 500/mm3 or less in the next 48 hours.
What would indicate an infection of the GI tract
Abdominal pain, mucositis at any level of the digestive tract, and diarrhea
What would indicate an infection of the genitourinary tract?
Dysuria, frequency, urgency, hematuria, cloudy urine, flank pain, perineal itching, and vaginal discharge
What would indicate an infection of the head and neck
Swelling, itching, eye redness or drainage, ear pain or discharge, nasal congestion or drainage, oral ulcerations, and difficulty breathing
What would indicate an infection of hematologic/immunologic
Decrease in diastolic BP, headache, oliguria, and flushed appearance
What would indicate an infection of the CNS
Change in mental status, headache, seizure, vision changes, photosensitivity, nausea and lethargy